Italfarmaco Provides Overview on Givinostat as Treatment for Duchenne Muscular Dystrophy: Progress in Global Access, Regulatory Milestones and Clinical Trials

06 Marzo 2025

Sede legale e stabilimento

ITALFARMACO S.p.A.
Viale Fulvio Testi, 330
20126 Milano
Tel. +39 02 64431
Fax +39 02 644346 / +39 02 66102753

ITALFARMACO S.p.A.
Via dei Lavoratori, 54
20092 Cinisello Balsamo (MI)
Tel. +39 02 64431
Fax +39 02 6424790

C.F. e Partita I.V.A. 00737420158